SCHEMBL13770482

SCHEMBL13770482

NCCC(=O)c1ccc(F)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.69
RAB9A P51151 1/20 0.69
HTR7 P34969 1/20 0.60
PTPN1 P18031 1/20 0.57
HSD11B1 P28845 2/20 0.54
CES2 O00748 1/20 0.50
CES1 P23141 1/20 0.50
PLOD2 O00469 1/20 0.50
KDM4E B2RXH2 1/20 0.49
HSD17B10 Q99714 1/20 0.49
KMT2A Q03164 3/20 0.49
MAPT P10636 2/20 0.49
MEN1 O00255 2/20 0.49
HTT P42858 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
CTNNB1 P35222 1/20 0.49
HPGD P15428 1/20 0.49
ALOX12 P18054 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
PAX8 Q06710 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL20491214 0.98 NPC1 (0.67) NPC1RAB9AHTR7PTPN1HSD11B1
SCHEMBL11490646 0.94 RAB9A (0.62) NPC1RAB9AHTR7PTPN1HSD11B1
SCHEMBL16853371 0.89 L3MBTL1 (0.52) NPC1RAB9AHTR7CES1KDM4E
SCHEMBL15607726 0.88 NPC1 (0.77) NPC1RAB9AHTR7PTPN1HSD11B1
SCHEMBL26584242 0.86 NPC1 (0.82) NPC1RAB9AHTR7PTPN1HSD11B1
SCHEMBL633279 0.84 NPC1 (0.72) NPC1RAB9AHTR7PTPN1HSD11B1
SCHEMBL4485908 0.83 RAB9A (0.69) NPC1RAB9AHTR7PTPN1HSD11B1
SCHEMBL9680520 0.82 NPC1 (0.91) NPC1RAB9AHTR7PTPN1HSD11B1
SCHEMBL1779295 0.82 NPC1 (0.61) NPC1RAB9AHTR7PTPN1HSD11B1
SCHEMBL28882512 0.81 NPC1 (0.80) NPC1RAB9AHTR7PTPN1HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009094169-A1 CYCLIC CARBAZATE AND SEMICARBAZIDE INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1 VITAE PHARMACEUTICALS, INC. (US) 2009-07-30 WO disclosed
US-7368467-B2 Calcium channel modulators 2-(alkyl or (hetero)arylalkylthio)-imidazoles and S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders WYETH (US) 2008-05-06 US disclosed
US-7368467-B2 Calcium channel modulators 2-(alkyl or (hetero)arylalkylthio)-imidazoles and S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders WYETH (US) 2008-05-06 US disclosed